IMAGEN PET-TC EN EL MANEJO DEL NODULO PULMONAR Y EN EL CANCER DE PULMON NO MICROCITICO
Palabras clave:
PET, TC, nódulo, pulmón, pulmonarResumen
Describir la utilidad de la imagen PET-TC tanto en el nódulo pulmonar como en el manejo del paciente con CPNM. Explicar el rendimiento en la estadificación N frente a otras pruebas diagnósticas. Exponer la importancia de la imagen metabólica en la planificación de radioterapia, en la detección de recidivas y en la respuesta a los tratamientos
Descargas
Citas
-Positron emission tomography/computerized tomography in lung cancer. Sahiner I, Vural GU. Quant Imaging Med Surg. 2014 Jun;4(3):195-206
- Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Shen G, Hu S, Deng H, Jia Z. Acta Radiol. 2015 Jun;56(6):681-7
-Diagnostic accuracy of FDG PET/CT in mediastinal lymph nodes from lung cancer. Ambrosini V, Fanti S, Chengazi VU, Rubello D. Eur J Radiol. 2014 Aug;83(8):1301-2.
-The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Lu P, Sun Y, Sun Y, Yu L. Lung Cancer. 2014 Jul;85(1):53-8
-FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).
Vera P, Mezzani-Saillard S, Edet-Sanson A, Ménard JF, Modzelewski R, Thureau S, Meyer ME, Jalali K, Bardet S, Lerouge D, Houzard C, Mornex F, Olivier P, Faure G, Rousseau C, Mahé MA, Gomez P, Brenot-Rossi I, Salem N, Dubray B. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1057-65
-Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC.
Bahce I, Vos CG, Dickhoff C, Hartemink KJ, Dahele M, Smit EF, Boellaard R, Hoekstra OS, Thunnissen E. Lung Cancer. 2014 Aug;85(2):205-12.
-Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
Reyes N, Onadeko OO, Luraschi-Monjagatta Mdel C, Knox KS, Rennels MA, Walsh TK, Ampel NM. Lung. 2014 Aug;192(4):589-93
-Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot Experience.
Genestreti G, Burgio MA, Matteucci F, Piciucchi S, Scarpi E, Monti M, Bucchi L, Parisi E, Crociani L, Gurioli C, Poletti V, Gavelli G. Technol Cancer Res Treat. 2015 Dec;14(6):721-7
-Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients. Antoniou AJ, Marcus C, Tahari AK, Wahl RL, Subramaniam RM. J Nucl Med. 2014 Jul;55(7):1062-8.
-Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Su M, Li Y, Li F, Li L, Tian R. Nucl Med Commun. 2014 Sep;35(9):916-21
-Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Olivier A, Petyt G, Cortot A, Scherpereel A, Hossein-Foucher C. Nucl Med Commun. 2014 Sep;35(9):908-15
-PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ. J Nucl Med. 2014 May;55(5):724-9
-Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PET.
Morimoto D, Takashima S, Sakashita N, Sato Y, Jiang B, Hakucho T, Miyake C, Takahashi Y, Tomita Y, Nakanishi K, Hosoki T, Higashiyama M. Acta Radiol. 2014 Jun;55(5):563-9.
-Role of imaging in diagnosis, staging and follow-up of lung cancer.
De Wever W, Verschakelen J, Coolen J. Curr Opin Pulm Med. 2014 Jul;20(4):385-92
- (18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
van Gool MH, Aukema TS, Schaake EE, Rijna H, Codrington HE, Valdés Olmos RA, Teertstra HJ, van Pel R, Burgers SA, van Tinteren H, Klomp HM. Ann Surg Oncol. 2014 Sep;21(9):2831-7
-Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC? Inal A, Kaplan MA, Kucukoner M, Urakci Z, Dostbil Z, Komek H, Onder H, Tasdemir B, Isikdogan A. Contemp Oncol (Pozn). 2014;18(2):106-10.
-Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
Sasada S, Miyata Y, Tsubokawa N, Mimae T, Yoshiya T, Okada M. Ann Thorac Surg. 2014 Aug;98(2):417-22.
